Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
GH/IGF-I axis and matrix adaptation of the musculotendinous tissue to exercise in humans
Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds
Their higher absorption rate allows you to feel the benefits much faster
B12 shots are also not recommended if you have a history of issues like leukemia, myeloma, or certain types of anemia not caused by B12 deficiency
Patients interested in medical weight loss should speak with a licensed provider about currently available options, including tirzepatide and semaglutide when clinically appropriate
US$ 27.83
US$ 22.72
US$ 24.52